Burnt-out Metastatic Prostate Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A burnt-out prostate cancer tumor is a very rare clinical entity. The term ‘burnt-out’ refers to a primary tumor that has spontaneously and nearly completely regressed without treatment. Since metastasis of prostate cancer is usually encountered in the presence of advanced disease, distant metastasis with an undetectable primary tumor is very rare. We report herein a case of a burnt-out prostate cancer tumor that metastasized to the thoracic (T) spine and caused cord compression. A 66-year-old man visited the Emergency Department due to weakness of both legs for the past two days. His blood and urine tests were normal at the time. His spine magnetic resonance imaging (MRI) scans looked like bone metastasis that involved the T-7 vertebral body and a posterior element, and caused spinal cord compression. Other images, including from the brain MRI, neck/chest/abdomino-pelvic computed tomography (CT) scan and 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) and endoscopy, revealed no lesions that suggested malignancy. After total corpectomy T-7 and screw fixation/fusion at T5 to T10, the pathology report revealed a metastatic carcinoma that was strongly positive for prostate-specific antigen (PSA). The serum PSA value was 1.5 ng/mL. The transrectal 12-core prostate biopsy and ultrasonography showed no definitive hypoechoic lesion, but one specimen had slight (only 1%) adenocarcinoma with a Gleason score of 6 (3+3). The final diagnosis was burned-out prostate cancer with an initial normal PSA value. Although metastatic disease with an unknown primary origin was confirmed, a more aggressive approach in seeking the primary origin could provide a more specific treatment strategy and greater clinical benefit to patients.
Abstract
A burnt-out prostate cancer tumor is a very rare clinical entity. The term ‘burnt-out’ refers to a primary tumor that has spontaneously and nearly completely regressed without treatment. Since metastasis of prostate cancer is usually encountered in the presence of advanced disease, distant metastasis with an undetectable primary tumor is very rare. We report herein a case of a burnt-out prostate cancer tumor that metastasized to the thoracic (T) spine and caused cord compression. A 66-year-old man visited the Emergency Department due to weakness of both legs for the past two days. His blood and urine tests were normal at the time. His spine magnetic resonance imaging (MRI) scans looked like bone metastasis that involved the T-7 vertebral body and a posterior element, and caused spinal cord compression. Other images, including from the brain MRI, neck/chest/abdomino-pelvic computed tomography (CT) scan and 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) and endoscopy, revealed no lesions that suggested malignancy. After total corpectomy T-7 and screw fixation/fusion at T5 to T10, the pathology report revealed a metastatic carcinoma that was strongly positive for prostate-specific antigen (PSA). The serum PSA value was 1.5 ng/mL. The transrectal 12-core prostate biopsy and ultrasonography showed no definitive hypoechoic lesion, but one specimen had slight (only 1%) adenocarcinoma with a Gleason score of 6 (3+3). The final diagnosis was burned-out prostate cancer with an initial normal PSA value. Although metastatic disease with an unknown primary origin was confirmed, a more aggressive approach in seeking the primary origin could provide a more specific treatment strategy and greater clinical benefit to patients.
참고문헌 (19)
- Bubendorf L, "Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients", Hum Pathol, 31, pp.578~583 (2000)
- Chybowski FM, "Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters", J Urol, 145, pp.313~318 (1991)
- Wang ZL, "Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer", Zhonghua Nan Ke Xue, 11, pp.825~827 (2005)
- Lopez JI, "Burned-out tumour of the testis presenting as retroperitoneal choriocarcinoma", Int Urol Nephrol, 26, pp.549~553 (1994)
- Siegel R, "Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths", CA Cancer J Clin, 61, pp.212~236 (2011)
- Rao AR, "The discovery of prostate-specific antigen", BJU Int, 101, pp.5~10 (2008)
- Polascik TJ, "Prostate specific antigen:a decade of discovery--what we have learned and where we are going", J Urol, 162, pp.293~306 (1999)
- Stamey TA, "Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients", J Urol, 141, pp.1088~1090 (1989)
- Thobe MN, "From prostate to bone: key players in prostate cancer bone metastasis", Cancers (Basel), 3, pp.478~493 (2011)
- Yamamoto S, "M1 prostate cancer with a serum level of prostate-specific antigen less than 10 ng", mL, 2001, pp.8, 374~379
- Nishio R, "Metastatic prostate cancer with normal level of serum prostate-specific antigen", Int Urol Nephrol, 35, pp.189~192 (2003)
- Leibovici D, "Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level", Cancer, 109, pp.198~204 (2007)
- 이동길, "Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific Antigen", Investigative and Clinical Urology, 51(5), pp.358~361 (2010), 대한비뇨기과학회
- DiGiuseppe JA, "Increasing incidence of minimal residual cancer in radical prostatectomy specimens", Am J Surg Pathol, 21, pp.174~178 (1997)
- Bostwick DG, "‘Vanishing’ prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases", BJU Int, 94, pp.57~58 (2004)
- Moskaluk CA, "Vanishing prostate cancer syndrome: symptom of a larger clinical issue", Am J Surg Pathol, 29, pp.561~563 (2005)
- Trpkov K, "No residual cancer on radical prostatectomy after positive 10-core biopsy: incidence, biopsy findings, and DNA specimen identity analysis", Arch Pathol Lab Med, 130, pp.811~816 (2006)
- Ebel Sepúlveda L, "Vanishing prostate cancer. clinical presentation and histological review", Actas Urol Esp, 33, pp.956~959 (2009)
- 이승렬, "병리학적 T0 병기 전립선암의 병리학적 특성과 예후", Investigative and Clinical Urology, 50(3), pp.229~236 (2009), 대한비뇨기과학회